Vimarsana
Biggest News Aggregation in the World

Page 8 - Liver Function News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Liver Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Liver Function Today - Breaking & Trending Today

Direct-Acting Antivirals Improve HCC-Free Survival, Liver Function in Patients with HCV Decompensated Cirrhosis - Vimarsana News

Direct-Acting Antivirals Improve HCC-Free Survival, Liver Function in Patients with HCV Decompensated Cirrhosis

Results from the systematic review and meta-analysis demonstrated the positive effect of DAA therapy on overall survival, HCC-free survival, and liver function among patients with HCV decompensated cirrhosis compared to a non-DAA control group.

The Future of Liver Function Assessments in HCC - Vimarsana News

The Future of Liver Function Assessments in HCC

Experts emphasize the importance of using multiple liver function assessments for more comprehensive patient evaluation in hepatocellular carcinoma treatment.

Key Outcomes Data in Patients With HCC Based on Liver Function - Vimarsana News

Key Outcomes Data in Patients With HCC Based on Liver Function

Amit Singal, MD, reviews analyses of the HIMALAYA and KEYNOTE-240 trials, focusing on the impact of liver function via ALBI grades on treatment outcomes and safety in patients with hepatocellular carcinoma.

Rivoceranib plus Camrelizumab for First-Line Treatment of HCC: Data from CARES-310 - Vimarsana News

Rivoceranib plus Camrelizumab for First-Line Treatment of HCC: Data from CARES-310

Rachna Shroff, MD, MS, FASCO, shares data from the CARES-310 study showing improved progression-free and overall survival in patients with hepatocellular carcinoma treated with camrelizumab and rivoceranib compared to sorafenib, regardless of liver function.

Helping the liver regenerate itself could give patients with end-stage liver disease a treatment option besides waiting for a transplant - Vimarsana News

Helping the liver regenerate itself could give patients with end-stage liver disease a treatment option besides waiting for a transplant

Tylenol overdose is one of the leading causes of liver injury requiring liver transplantation. Elena Merkulova/iStock via Getty ImagesThe liver is known for its ability to regenerate. It can completely regrow itself even after two-thirds of its mass has been surgically removed. But damage from medications, alcohol abuse or obesity can eventually cause the liver to fail. Currently, the only effective treatment for end-stage liver disease is transplantation. However, there is a dearth of organs av

Source: yahoo.com